the aid library

LIST OPTIONS

Filter

8305

Les maladies diarrhéiques aiguës dans les situations d'urgence complexes: mesures essentielles

Organisation Mondiale de la Santé OMS (2011) C_WHO

Le document fournit des directives essentielles pour prévenir et gérer les maladies diarrhéiques aiguës, en particulier dans les situations d'urgence complexes comme les conflits, les catastrophes naturelles ou les crises sanitaires. Il met en avant l'importance de l'accès à l'eau potable, de ... more

Download (182)

View PDF (170)

Traitement d’urgence du paludisme sévère chez l’enfant par application intranasale d’artésunate

Yobouet I.K. Université Claude Bernard Lyon (2022) C2

La thèse de Yobouet Inès Kouakou, soutenue à l’Université Claude Bernard Lyon 1, porte sur le traitement d’urgence du paludisme sévère chez l’enfant à l’aide d’une administration intranasale d’artésunate. L’objectif principal de ce travail est d’explorer, in vitro, la voie na... more

Download (62)

View PDF (63)

Malaria in Children

Temu A., Kabyemela G. (2025) C2

Malaria in children presents significant clinical challenges, with variations in presentation based on the malaria parasite involved and the child's underlying health conditions. The World Health Organization reports high incidence rates, particularly in sub-Saharan Africa, and emphasizes the import... more

Download (93)

View PDF (67)

Campagne de communication sur la Chimio prévention du paludisme au Cameroun

Mengue Embolo J.I. Republic of Cameroun (2023) C2

Le mémoire porte sur la conception et la mise en œuvre d’une campagne de communication pour promouvoir la chimio-prévention du paludisme saisonnier (CPS) chez les enfants de 3 à 59 mois au Cameroun, une stratégie recommandée par l’OMS dans les zones de forte transmission saisonnière. L’... more

Download (148)

View PDF (83)

Directives nationales pour la prise en charge du paludisme en République Démocratique du Congo

Programme National de Lutte contre le Paludisme (PNLP) Ministère de la Santé Publique, Hygiène et Prévention, République Démocratique du Congo (2023) C2

Le document « Directives nationales pour la prise en charge du paludisme en RDC », publié en 2023 par le PNLP et le Ministère de la Santé, définit les protocoles officiels pour diagnostiquer et traiter le paludisme sur l’ensemble du territoire. Il recommande l’usage systématique du te... more

Download (836)

View PDF (1551)

Gestion des dépouilles mortelles lors de catastrophes : manuel pratique à l’usage des premiers intervenants. 2ième éd., rév.

Cordner, S.; Coninx, R.; Kim, J.-J. et al. (Éd.) Organisation mondiale de la santé (OMS), Organisation panaméricaine de la santé, Fédération internationale des Sociétés de la Croix-Rouge et du Croissant-Rouge (2016) C_WHO

La deuxième édition de ce manuel fournit des directives simples, concrètes et faciles à suivre pour la récupération et le stockage des corps des personnes décédées lors de catastrophes et l’enregistrement des informations les concernant, l’objectif étant d’aider les premiers interven... more

External Link

Health care waste management assessment tool

World Health Organization (2001)

External Link

Poorly Designed PPE a Global Problem forWomen HealthWorkers

Kuehn, B.M. (2022) C1

Download (513)

View PDF (733)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (2397)

View PDF (3728)

For Proper Disposal Hospital Waste

Jorge Emmanuel and Ruth Stringer Health Care Without Harm (2007)

A Global Inventory of Alternative Medical Waste Treatment Technologies

External Link

Règlement sanitaire international (2005) Domaines de travail pour la mise en oeuvre du Règlement

Organisation de la Santé Mondiale (2007)

Download (758)

View PDF (1457)

SSI Prevention - CORRECT AND SAFE SURGICAL ANTIBIOTIC PROPHYLAXIS

Surgical Unit-based Safety Program World Health Organisation (WHO) (2018) C_WHO

Download (1151)

View PDF (1825)

HIV Prevention Protocols

World Health Organization (2014) C_WHO

Accessed 24 June 2014

Download (413)

View PDF (571)

Colaboración entre el sector de WASH y el sector de la salud: Guía práctica para los programas de lucha contra las enfermedades tropicales desatendidas. Segunda edición corregida
recommended

Organización Mundial de la Salud OPS (2023) C_WHO

La atención concedida a la equidad en la Agenda 2030 para el Desarrollo Sostenible obliga a encontrar nuevas formas de ampliar progresivamente los servicios a las poblaciones que no los reciben. Las alianzas satisfactorias entre el sector encargado del suministro de agua, el saneamiento y la higien... more

Download (1651)

View PDF (2324)

Quality Assessment Guidebook: A guide to assessing health services for adolescent clients.

World Health Organization (WHO) (2009) C_WHO

Over the past few decades and throughout the world, the landscape of adolescent health has been altered dramatically. Currently, the total population of adolescents between the ages of 10 and 19 years is 1.2 billion – the largest generation of young people in history. The vast majority of adolesce... more

Download (276)

View PDF (320)

The adolescent health indicators recommended by the Global Action for Measurement of Adolescent Health: Guidance for monitoring adolescent health at country, regional and global levels

UN Children's Fund UNICEF; UN Educational, Scientific and Cultural Organization UNESCO; UN Women; UNAIDS; United Nations Population Fund UNPF; World Bank; World Food Programme WFP; World Health Organization WHO (2024) C_WHO

Adolescence is a critical stage in life for physical, cognitive and emotional development, shaping future health and well-being. Comprehensive measurement of adolescent health is essential to prioritize health issues, guide interventions and track progress. However, global, regional and national ado... more